ABA Life Partners with Admaius Capital for Major Growth
In a landmark development for Morocco's burgeoning healthtech sector, ABA Life has entered into a $40 million investment agreement with pan-African private equity firm Admaius Capital Partners. This agreement, which is contingent upon customary closing conditions and the approval from Morocco's Competition Council, marks a pivotal moment in the company's journey to establish itself as a global leader in healthcare innovation.
Founded in 2021, ABA Life serves as the healthcare division of ABA Technology, which is chaired by the visionary entrepreneur Mohamed Benouda. The company has successfully developed a comprehensive suite of healthcare solutions that leverage cutting-edge technologies including artificial intelligence, medical technology, telemedicine, and connected healthcare infrastructure. These innovations are not only reshaping how healthcare is delivered but are also expanding access to essential medical services across the nation.
ABA Life has established a robust and profitable business model that facilitates healthcare programs in collaboration with public institutions and philanthropic foundations, thereby enhancing healthcare accessibility for diverse populations. The newly secured investment will be instrumental in advancing the company's ambitious "AI for Sovereign Health" initiative, which encompasses the Mediot AI platform and various clinical intelligence solutions. Furthermore, it will enable ABA Life to broaden its healthcare technologies and services while making inroads into international markets.
Future Growth and Expansion Plans
This investment signifies a new chapter in ABA Life's growth strategy, focusing on three primary objectives: accelerating its AI for Sovereign Health program, industrializing its healthcare technologies for widespread deployment, and fostering international expansion. By harnessing its technological capabilities and operational expertise, ABA Life aspires to create a next-generation HealthTech platform that combines AI and medical innovation with operational excellence, aiming to establish itself as one of Morocco's forthcoming technology unicorns.
“In just five years, we have demonstrated that a profitable healthcare technology model capable of scaling can emerge from Morocco. This funding signifies the beginning of a new phase: acceleration and internationalization. Our vision is to position ABA Life as a global benchmark in healthtech and to develop a new generation of clinical intelligence in Morocco that can compete in international markets,” stated Mohamed Benouda, Founder and Chairman of ABA Technology.
Selim Ettriqui, Head of Morocco and West Africa at Admaius Capital Partners, expressed enthusiasm about the partnership, stating, “From our initial discussions, we were struck by what ABA Life has accomplished: an integrated healthcare operator that combines medical devices, connected infrastructure, care operations, and proprietary technology developed in Morocco. We are excited to support Mohamed Benouda and his team as they embark on this new phase of growth and international reach.”
Marlon Chigwende, Managing Partner at Admaius Capital Partners, highlighted the qualities that attracted their investment, emphasizing ABA Life's ambitious entrepreneurial team, proven business model, and strong technological foundation that possesses significant potential for scaling. He expressed confidence in the company's ability to become a leading international reference in healthtech and underscored Admaius's commitment to supporting this vision.
As reported by wamda.com.
